165 related articles for article (PubMed ID: 31261874)
1. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo.
Matsui T; Chiyo T; Kobara H; Fujihara S; Fujita K; Namima D; Nakahara M; Kobayashi N; Nishiyama N; Yachida T; Morishita A; Iwama H; Masaki T
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261874
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo.
Fujita N; Fujita K; Iwama H; Kobara H; Fujihara S; Chiyo T; Namima D; Yamana H; Kono T; Takuma K; Hirata M; Kobayashi K; Kato K; Kamada H; Morishita A; Tsutsui K; Himoto T; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2020 Jul; 44(1):339-348. PubMed ID: 32627043
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.
Kobara H; Fujihara S; Iwama H; Matsui T; Fujimori A; Chiyo T; Tingting S; Kobayashi N; Nishiyama N; Yachida T; Tadokoro T; Oura K; Tani J; Fujita K; Nomura T; Yoneyama H; Morishita A; Okano K; Suzuki Y; Mori H; Masaki T
Mol Med Rep; 2020 Aug; 22(2):1063-1071. PubMed ID: 32626983
[TBL] [Abstract][Full Text] [Related]
7. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
8. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.
Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X
Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma.
Chen YH; Huang CH; Lu HI; Chen CH; Huang WT; Hsieh MJ; Rau KM; Chang AY; Lin WC; Li SH
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1185-92. PubMed ID: 24961505
[TBL] [Abstract][Full Text] [Related]
12. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
[TBL] [Abstract][Full Text] [Related]
13. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
14. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ
Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells.
Yamana Y; Fujihara S; Kobara H; Oura K; Samukawa E; Chiyo T; Okamura M; Yamana H; Tadokoro T; Fujita K; Morishita A; Iwama H; Masaki T
J Cancer Res Ther; 2022 Dec; 18(Supplement):S305-S312. PubMed ID: 36510981
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
[TBL] [Abstract][Full Text] [Related]
18. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
[TBL] [Abstract][Full Text] [Related]
20. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.
Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G
Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
